Publication Name	World Journal of Clinical Cases
Manuscript ID	89174
Country	China

Received	2023-10-23 02:51
Peer-Review Started	2023-10-23 02:53
First Decision by Editorial Office Director	2023-11-22 02:57
Return for Revision	2023-11-22 02:57
Revised	2023-12-04 02:09
Publication Fee Transferred
Second Decision by Editor	2024-01-05 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-01-05 06:44
Articles in Press	2024-01-05 06:44
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-18 07:38
Publish the Manuscript Online	2024-01-25 08:28

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Case Report
Article Title	Individualized anti-thrombotic therapy for acute myocardial infarction complicated with left ventricular thrombus: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yan Song, Hua Li, Xia Zhang, Lei Wang, Hong-Yan Xu, Zhi-Chao Lu, Xiao-Gang Wang and Bo Liu
Funding Agency and Grant Number
Corresponding Author	Bo Liu, PhD, Doctor, Doctor, Department of Pulmonary and Critical Care Medicine, Department of Clinical Microbiology, Zibo City Key Laboratory of Respiratory Infection and Clinical Microbiology, Zibo City Engineering Technology Research Center of Etiology Molecular Diagnosis, Zibo Municipal Hospital, No. 139 Luan Road, Linzi District, Zibo 255400, Shandong Province, China. lwmx@foxmail.com
Key Words	Myocardial infarction; Left ventricular thrombus; Dabigatran etexilate; Warfarin; Clinical pharmacist; Case report
Core Tip	Current guidelines predominantly offer low-grade recommendations favoring warfarin combined with DAPT for treating left ventricular thrombus (LVT) in acute myocardial infarction, unless contraindicated. However, the ideal duration of this triple therapy remains uncertain. Despite vitamin K antagonists being the preferred oral anticoagulant, it is unclear whether non-vitamin K antagonist oral anticoagulants exhibit distinct effectiveness in LVT treatment. This case report emphasizes that not all patients have sufficient evidence supporting the use of direct-acting oral anticoagulants in LVT management, and the recommended duration of triple therapy is six months.
Publish Date	2024-01-25 08:28
Citation	Song Y, Li H, Zhang X, Wang L, Xu HY, Lu ZC, Wang XG, Liu B. Individualized anti-thrombotic therapy for acute myocardial infarction complicated with left ventricular thrombus: A case report. World J Clin Cases 2024; 12(4): 835-841
URL	https://www.wjgnet.com/2307-8960/full/v12/i4/835.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i4.835

Full Article (PDF)	WJCC-12-835-with-cover.pdf
Full Article (Word)	WJCC-12-835.docx